Botulinum toxin type A therapy for bilateral focal neuropathic pruritus in multiple sclerosis: a case report

Int J Rehabil Res. 2021 Dec 1;44(4):382-383. doi: 10.1097/MRR.0000000000000495.

Abstract

Neuropathic pruritus is a form of chronic itch that occurs in the presence of direct damage to the nervous system. It tends to be severe, disabling, and difficult to treat. Usual antipruritic medications are largely ineffective and there is no consensus regarding the treatment approach. The authors report a case of a 58-year-old man with primary progressive multiple sclerosis and a history of unsatisfactory management of severe bilateral focal pruritus. Significant symptom relief was attained after local intradermal injections of botulinum toxin type A.

Publication types

  • Case Reports

MeSH terms

  • Botulinum Toxins, Type A* / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis* / complications
  • Multiple Sclerosis* / drug therapy
  • Peripheral Nervous System Diseases*
  • Pruritus / drug therapy

Substances

  • Botulinum Toxins, Type A